Fungal Diseases

Additional Information for Pneumocystis pneumonia

MMWR Articles:

Treating Opportunistic Infections among HIV-Infected Adults and Adolescents. MMWR Recommendations and Reports, December 17, 2004/53(RR15); 1-112.

Revised Guidelines for Prophylaxis against Pneumocystis carinii Pneumonia for Children Infected with or Perinatally Exposed to Human Immunodeficiency Virus. MMWR Recommendations and Reports, April 28, 1995/44(RR-4); 1-11.

Pneumocystis Pneumonia ---Los Angeles. MMWR Weekly, June 5, 1981/30(21); 1-3.

Publications:

Harris, J. R., S. A. Balajee, et al. (2010). "Pneumocystis Jirovecii Pneumonia: Current Knowledge and Outstanding Public Health Issues." Curr Fungal Infect Rep 4(4): 229-237.

Kelley, C. F., W. Checkley, et al. (2009). "Trends in hospitalizations for AIDS-associated Pneumocystis jirovecii Pneumonia in the United States (1986 to 2005)." Chest 136(1): 190-197.

Medrano, F., M. Montes-Cano, et al. (2005). "Pneumocystis jirovecii in General Population." Emer Infect Dis 11(2): 245-250.

Sing, A., K. Trebesius et al. (2000). "Evaluation of Diagnostic Value and Epidemiological Implications of PCR for Pneumocystis carinii in Different Immunosuppressed and Immunocompetent Patient Groups." J Clin Microbiol 38(4): 1461-1467.

Wakefield, A. E., A. R. Lindley, et al. (2003). "Limited asymptomatic carriage of Pneumocystis jirovecii in human immunodeficiency virus-infected patients." J Infect Dis 187(6): 901-908.